|
Tanzania Journal of Health Research
Health User's Trust Fund (HRUTF)
ISSN: 1821-6404
Vol. 17, No. 4, 2015, pp. 1-6
|
Bioline Code: th15033
Full paper language: English
Document type: Research Article
Document available free of charge
|
|
Tanzania Journal of Health Research, Vol. 17, No. 4, 2015, pp. 1-6
en |
Immune recovery among HIV-infected patients in northwestern Tanzania after 2 years of anti-retroviral therapy use: a retrospective cohort study
MPONDO, BONAVENTURA C.T.; KABANGILA, RODRICK; EPHRAIM, LUCHERI; ERNEST, ALEX & KIDENYA, BENSON R.
Abstract
Background: The use of antiretroviral therapy (ART) for the treatment of human immunodeficiency
virus (HIV) is associated with significant and sustained decrease in the viral RNA levels that allows the
immune system to recover. The extent of this immune recovery depends on the baseline CD4 count.
Evidence on the extent of immune recovery in patients with advanced HIV from resource limited
settings is scarce. The objective of this study was to determine immune recovery in a cohort of HIV
infected outpatients after using ART for a period of 2 years
Methods: This retrospective cohort study was conducted in an outpatient HIV clinic at Bugando
Medical Centre in northwestern Tanzania. CD4+ T-cell counts for HIV-positive adults at the time of
enrolment were measured and retrospectively followed up during ART eligibility screening process
prior to initiation of antiretroviral (ARV) drugs. We then compared the CD4+ T-cell counts at baseline
and that during the enrolment.
Results: A total of 238 patients files were screened for enrolment. Of the 238 patients, 171 (71.8%)
fulfilled the criteria and were enrolled for the study. The lack of participation was due to death 17
(7.1%), lost to follow-up 32 (13.4%) and refusal 18 (9.5%). Of the 171 patients, the median CD4 count at
the time of ART initiation was 153 cells/μl [Interquartile range (IQR): 78 – 199], 164 (95.9%) had
increased their CD4 cells count, with 74.3% having an increase of more than 150 cells/μl. Only 8 (4.7%)
patients had a decline of CD4 cell count. The median CD4 cells count after a 2-year follow up was
significantly higher (396 [IQR: 295 – 567]) than at baseline (153 [IQR: 78 – 199]) cells/ul; p-value
<0.0001).
Conclusion: The CD4 cells count increased significantly after a follow up period of 2 years after ART
use in this cohort. Early diagnosis and ART initiation could therefore improve outcomes in HIV-infected
patients in resource limited settings.
Keywords
HIV; antiretroviral therapy; Immune recovery; Tanzania
|
|
© Copyright 2015 - Tanzania Journal of Health Research
|
|